Session: 722. Allogeneic Transplantation: Acute and Chronic GVHD and Immune Reconstitution: Poster III
Hematology Disease Topics & Pathways:
Research, Translational Research, Immunology, Biological Processes, Microbiome, Study Population, Animal model
Methods: C57BL/6 mice were purchased from JAX and TAC Laboratories. Vendor-driven microbiota diversity was preserved or enriched by separate housing or a co-housing approach (3 mice from vendor 1 mixed with 2 mice from vendor 2) for 2 weeks. Non-cohoused mice and co-housed mice were lethally irradiated (9 Gy) then transplanted with 5 x 10E6 T cell-depleted bone marrow (TCDBM) cells with or without 0.5 x 10E6 T cells from MHC-mismatched FVB/FVB-luc+ mice and monitored for survival. Stool samples were collected prior to co-housing, after co-housing, and at serial time points post-transplant. Microbial diversity was analyzed with CosmosID following shallow shotgun sequencing.
Results: Our study yielded a significant finding of higher GvHD-mortality rate (p<0.04) in non-cohoused TAC mice, with 50% mortality over 60 days post-allo-BMT, compared to 10% mortality in JAX mice. Taxonomic sequencing analysis revealed greater microbial diversity in the gut of TAC mice relative to JAX, with a higher Shannon index for alpha-diversity (p=0.002). The Bacillota to Bacteroidota ratio was significantly higher (p=0.007) in TAC mice compared to JAX. TAC mice had more Th17 and Th1-inducing bacterial strains than JAX mice, such as Prevotella, L. reuteri, M. schaedleri, and B. fragilis. In contrast, TAC mice had fewer Muribaculaceae species and Akkermansia muciniphila. Following the co-housing of JAX and TAC mice, the microbiota diversity of JAX mice shifted to a TAC phenotype as determined by the Jaccard dissimilarity matrix. JAX mice co-housed with TAC mice were more vulnerable to GvHD, with 40% mortality compared to non-cohoused JAX mice (p<0.04). Co-housed JAX mice that developed lethal aGvHD trended towards higher pre-transplant ratios of stool Bacillota to Bacteroidota compared with co-housed JAX mice that did not develop lethal aGvHD (p<0.10).
Conclusion: The results indicate that murine GvHD survival is influenced by the ratio of Bacillota to Bacteroidota in the intestinal microbiome. Shotgun sequencing indicated an association of Prevotella, L. reuteri, M. schaedleri, and B. fragilis species with more severe GvHD. Profiling of metabolites involved in metabolic and catabolic pathways of the TAC and JAX microbiome will be analyzed in parallel with human plasma samples from BMT CTN studies of allogeneic transplants to identify metabolites and associated bacterial species that might provide clinical benefits in reducing aGvHD in transplant patients.
Disclosures: Waller: Sanofi: Consultancy, Membership on an entity's Board of Directors or advisory committees; Novartis: Consultancy, Membership on an entity's Board of Directors or advisory committees; Biolinerx: Consultancy, Membership on an entity's Board of Directors or advisory committees; Allogene: Consultancy, Membership on an entity's Board of Directors or advisory committees; CSL: Consultancy, Membership on an entity's Board of Directors or advisory committees; Forte Bioscience: Consultancy, Membership on an entity's Board of Directors or advisory committees; Cambium Medical Technologies: Current equity holder in private company; Cambium Oncology: Current equity holder in private company; Doximity: Current equity holder in private company.